Pharming (PHAR) Revenue (2020 - 2026)
Pharming's Revenue came in at $162.66 million for Q2 2026, down 5.6% from $172.32 million a year earlier but up 124.7% from the prior quarter.
Powered by 
Analysis
Pharming (PHAR) Revenue (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Pharming reported Revenue of $332.36 million, up 1.9% year-over-year; for FY2025, it came in at $376.13 million, up 26.6% from FY2024.
- Revenue has increased in each of the last four years, with a five-year compound annual growth rate of 12.1% (FY2020 to FY2025).
- Going back by year, Revenue was $297.2 million in FY2024 (+21.1%), $245.32 million in FY2023 (+19.3%), $205.62 million in FY2022 (+3.4%) and $198.87 million in FY2021 (-6.3%).
- The five-year range for quarterly Revenue is $74.10 (Q2 2024) to $172.32 million (Q2 2025).
- Year-over-year, Revenue increased in four of the last seven quarters, with an average decline of 2.1%.
- The fastest year-over-year change in Revenue over five years came in Q4 2023 (growth of 48.7%), and the weakest in Q4 2024 (a decline of 100.0%).
- Business Quant data shows PHAR's Revenue at $72.4 million (Q1 2026), $106.50 (Q4 2025) and $97.3 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Pharming | 738.17 Mn | -91.99 Mn | 141.47 Mn | 162.66 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 162.66 Mn |
| Mar 31, 2026 | 72.40 Mn |
| Dec 31, 2025 | 106.50 |
| Sep 30, 2025 | 97.30 Mn |
| Jun 30, 2025 | 172.32 Mn |
| Mar 31, 2025 | 79.10 Mn |
| Dec 31, 2024 | 92.70 |
| Sep 30, 2024 | 74.80 Mn |
| Jun 30, 2024 | 74.10 |
| Mar 31, 2024 | 55.60 Mn |
| Dec 31, 2023 | 81.20 Mn |
| Sep 30, 2023 | 66.66 Mn |
| Jun 30, 2023 | 54.90 Mn |
| Mar 31, 2023 | 42.54 Mn |
| Dec 31, 2022 | 54.60 Mn |
| Sep 30, 2022 | 54.20 Mn |
| Jun 30, 2022 | 50.10 Mn |
| Mar 31, 2022 | 46.60 Mn |
| Dec 31, 2021 | 146.10 Mn |
| Sep 30, 2021 | 52.63 Mn |
API Access
Pharming Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=PHAR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "PHAR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=PHAR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();